Originally published In Press as doi:10.1074/mcp.M800514-MCP200 on July 12, 2009.
Molecular & Cellular Proteomics 8:2285-2295, 2009.
© 2009 by The American Society for Biochemistry and Molecular Biology, Inc.
Research
Development and Evaluation of Normalization Methods for Label-free Relative Quantification of Endogenous Peptides*,
Kim Kultima , ,¶,
Anna Nilsson ,
Birger Scholz||,**,
Uwe L. Rossbach ,
Maria Fälth and
Per E. Andrén
From Medical Mass Spectrometry,
||Division of Toxicology, and
 Division of Biological Research on Drug Dependence, Department of Pharmaceutical Biosciences, Uppsala University, The Biomedical Center, Husargatan 3, Box 583, SE-75123 Uppsala, Sweden and
Department of Medical Sciences, Clinical Pharmacology, Uppsala University Hospital, 751 85 Uppsala, Sweden
The performances of 10 different normalization methods on data of endogenous brain peptides produced with label-free nano-LC-MS were evaluated. Data sets originating from three different species (mouse, rat, and Japanese quail), each consisting of 35–45 individual LC-MS analyses, were used in the study. Each sample set contained both technical and biological replicates, and the LC-MS analyses were performed in a randomized block fashion. Peptides in all three data sets were found to display LC-MS analysis order-dependent bias. Global normalization methods will only to some extent correct this type of bias. Only the novel normalization procedure RegrRun (linear regression followed by analysis order normalization) corrected for this type of bias. The RegrRun procedure performed the best of the normalization methods tested and decreased the median S.D. by 43% on average compared with raw data. This method also produced the smallest fraction of peptides with interblock differences while producing the largest fraction of differentially expressed peaks between treatment groups in all three data sets. Linear regression normalization (Regr) performed second best and decreased median S.D. by 38% on average compared with raw data. All other examined methods reduced median S.D. by 20–30% on average compared with raw data.
¶ Supported by funding from the "Emil and Ragna Börjessons" foundation. To whom correspondence should be addressed:Dept. of Medical Sciences, Clinical Pharmacology, Uppsala University Hospital, 751 85 Uppsala, Sweden. Tel.:4618-611-4241 or 4618-471-3678; Fax:4618-471-3692; E-mail:Kim.Kultima{at}medsci.uu.se.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
Copyright © 2009 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|